Pursuant to Regulation 30 read with Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Camlin Fine Sciences has informed that India Ratings & Research, through its letter dated May 13, 2020, has revised the outlook of the Company to Stable, from Negative, while reaffirming its Long Term Issuer rating at ‘IND BBB+’.
The above information is a part of company’s filings submitted to BSE.